The maker of the drug says it may stop after a large clinical trial showed patients didn't benefit

ALS drug will be pulled from US market after study showed patients didn't benefit. The maker of a drug for Lou Gehrig's disease that recently failed in a study says it will pull the medicine from the U.S. market. ALS drug will not be available in the United States for now.

ALS drug will be pulled from US market after study showed patients didn't benefit. The maker of a drug for Lou Gehrig's disease that recently failed in a study says it will pull the medicine from the U.S. market. ALS drug will not be available in the United States for now.

ALS drug Relyvrio failed large clinical trial and may be withdrawn from market. Amylyx Pharmaceuticals says its drug for amyotrophic lateral sclerosis, or ALS, did not show significant benefit in a large trial. RelyVrio, a drug for ALS, may be pulled from the market, company says.

Maker of much-debated ALS drug says it may stop selling it after study showed it didn't work. Maker of drug for Lou Gehrig's disease says it failed to help patients with the fatal disease. Drug maker says it will stop selling the drug after study shows it doesn't help patients.